The global industry was valued at US$ 22.2 Bn in 2022 and is estimated to grow at a CAGR of 6.1% from 2023 to 2031, reaching US$ 37.7 Bn by the end of 2031. The respiratory devices market is experiencing steady growth as the global burden of respiratory diseases continues to rise, driven by factors such as aging populations, increasing air pollution, and higher prevalence of chronic conditions like asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. The demand for advanced respiratory care solutions has significantly increased across hospitals, homecare settings, and emergency care environments, positioning this market as a critical component of the broader healthcare industry.

Access key findings and insights from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=28073

Market Overview

The respiratory devices market encompasses a wide range of equipment designed to assist, monitor, and treat patients with breathing disorders. These include therapeutic devices such as ventilators, continuous positive airway pressure (CPAP) machines, and oxygen concentrators, as well as diagnostic tools like spirometers and peak flow meters. The market has gained heightened attention following global health crises, which underscored the importance of respiratory care infrastructure. Technological advancements, including portable and wearable devices, telehealth integration, and smart monitoring systems, are transforming how respiratory conditions are managed. Additionally, increased awareness about early diagnosis and treatment is encouraging the adoption of these devices across both clinical and homecare settings.

Market Size and Growth

Valued at US$ 22.2 Bn in 2022, the respiratory devices market is projected to reach US$ 37.7 Bn by 2031, growing at a CAGR of 6.1%. This growth is fueled by rising healthcare expenditure, expanding access to medical technologies, and increasing demand for home-based care solutions. The growing geriatric population, which is more susceptible to respiratory ailments, is a key driver of market expansion. Furthermore, lifestyle factors such as smoking and exposure to environmental pollutants are contributing to the rising incidence of respiratory disorders, thereby increasing the need for effective treatment and monitoring devices. Continuous innovation in device design and functionality is also supporting sustained market growth.

Market Segmentation

The respiratory devices market can be segmented based on product type, application, and end-user. By product type, the market includes therapeutic devices, diagnostic devices, and monitoring equipment, with therapeutic devices accounting for a significant share due to their widespread use in treatment. In terms of application, the market addresses conditions such as COPD, asthma, sleep apnea, and infectious respiratory diseases. End-users include hospitals, clinics, homecare settings, and ambulatory care centers, with homecare emerging as a rapidly growing segment due to the convenience and cost-effectiveness of at-home treatment. Increasing demand for personalized and patient-centric solutions is influencing segmentation trends.

Regional Analysis

Regionally, North America dominates the respiratory devices market, driven by advanced healthcare infrastructure, high healthcare spending, and strong presence of leading market players. Europe also holds a substantial share, supported by increasing awareness of respiratory health and favorable reimbursement policies. Asia-Pacific is expected to witness the fastest growth during the forecast period, fueled by rising healthcare investments, growing population, and increasing prevalence of respiratory diseases in countries such as China and India. Meanwhile, Latin America and the Middle East & Africa are emerging markets, offering growth opportunities due to improving healthcare systems and increasing access to medical devices.

Competitive Landscape

The respiratory devices market is highly competitive, with several global players focusing on innovation, strategic collaborations, and expansion to strengthen their market positions. Key companies operating in this market include ResMed, Koninklijke Philips N.V., Vyaire Medical, Inc. (Becton, Dickinson and Company), Smiths Medical (part of Smiths Group plc), Fisher & Paykel Healthcare Limited, Drägerwerk AG & Co. KGaA, GE Healthcare (part of General Electric Company), Getinge AB, Medtronic plc, and Chart Industries. These companies are investing heavily in research and development to introduce advanced respiratory solutions, enhance product performance, and improve patient outcomes. Strategic partnerships and acquisitions are also common approaches to expanding market reach and capabilities.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact: 

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453